Pelage Pharmaceuticals
Biotechnology · Regenerative Medicine
Overview
Pelage Pharmaceuticals is developing PP405, a topical treatment designed to reactivate dormant hair follicle stem cells and restore natural hair growth.
Funding and backers
Backers
1
GV
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Cellcolabs produces GMP mesenchymal stem cells (MSCs) for clinical research and collaboration with clinics and scientists worldwide.
Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.
The growth of Revatis is supported by its innovative and patented technology to obtain multipotent adult mesenchymal stem cells from a…
Cellino is a Massachusetts biotechnology company founded in 2017. It automates stem cell manufacturing with laser editing, imaging and…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
GVVia a fund
569 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely